ARDS

Aridis Pharmaceuticals News

FREE ARDS REPORT

Company Name Stock Ticker Symbol Market Type
Aridis Pharmaceuticals Inc ARDS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.43 -34.96% 0.80 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.92 0.76 0.94 0.80 1.23
more quote information »

Recent News

Date Time Source Heading
1/26/20237:21IHNWFeaturedUCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023
1/25/202316:05GLOBEAridis Reports Top-Line Results of the Phase 3..
1/17/202316:30GLOBENew Approaches to Treating Infections in Cystic Fibrosis..
12/28/202208:30GLOBEAridis Pharmaceuticals to Discuss Topline Data from Phase 3..
12/15/202216:34EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
12/12/202212:25TRMNAridis Pharmaceuticals (ARDS) Gets a Buy from H.C...
12/12/202209:06EDGARCurrent Report Filing (8-k)
12/12/202208:05GLOBE(Updated) Aridis Pharmaceuticals Receives Equity Investment..
12/12/202207:00GLOBEAridis Pharmaceuticals Receives Equity Investment from the..
12/07/202216:52EDGARSecurities Registration Statement (s-1)
12/07/202209:04EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202209:03EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202209:02EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202209:02EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202209:01EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202209:00EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202208:59EDGARStatement of Changes in Beneficial Ownership (4)
12/07/202208:58EDGARStatement of Changes in Beneficial Ownership (4)
12/06/202206:02EDGARSecurities Registration: Employee Benefit Plan (s-8)
12/05/202207:00GLOBEAridis Signs Exclusive Terms to Secure Worldwide Commercial..
11/30/202214:50APSBiotech Pops On New Patient Enrollment Announcement
11/30/202207:00GLOBEAridis Announces a Key Milestone of Closing of Patient..
11/22/202209:10GLOBEAridis to Participate in Key Opinion Leader Discussion on..
11/22/202206:04EDGARCurrent Report Filing (8-k)
11/21/202218:30GLOBEAridis Pharmaceuticals Announces Third Quarter 2022..
11/21/202216:08EDGARQuarterly Report (10-q)
11/15/202206:22EDGARNotification That Quarterly Report Will Be Submitted Late..
10/06/202216:52EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
10/05/202207:02EDGARCurrent Report Filing (8-k)
10/04/202208:00PRNUSAridis Announces the Closing of Patient Enrollment in the..
9/27/202209:20PRNUSAridis Pharmaceuticals Announces Withdrawal of Public..
9/27/202208:26TRMNHere’s Why Aridis Pharmaceuticals Dropped 30%
9/26/202215:37PRNUSAridis Pharmaceuticals Announces Proposed Public Offering of..
9/26/202214:44EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
9/02/202217:28EDGARSecurities Registration Statement (simplified Form) (s-3)
8/16/202216:15PRNUSAridis Pharmaceuticals Announces Second Quarter 2022..
8/16/202206:11EDGARNotification That Quarterly Report Will Be Submitted Late..
8/16/202206:09EDGARQuarterly Report (10-q)
8/15/202217:53EDGARCurrent Report Filing (8-k)
8/10/202208:30PRNUSAridis' Pan-Coronavirus, Inhaled Monoclonal Antibody..
6/27/202216:47EDGARCurrent Report Filing (8-k)
6/08/202217:11EDGARStatement of Changes in Beneficial Ownership (4)
6/07/202206:27TRMNH.C. Wainwright Thinks Aridis Pharmaceuticals’ Stock is..
6/06/202217:01EDGARCurrent Report Filing (8-k)
6/03/202208:00PRNUSAridis Pharmaceuticals CEO to Participate in a Fireside Chat..
5/16/202217:53EDGARQuarterly Report (10-q)
5/16/202216:38EDGARCurrent Report Filing (8-k)
5/16/202216:05PRNUSAridis Pharmaceuticals Announces First Quarter 2022..
4/19/202211:37EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/19/202206:05EDGARProxy Statement (definitive) (def 14a)
4/13/202216:06EDGARAnnual Report (10-k)